MLLT3 and acute myeloid leukemia: Among the AML patients with MLL-AF9, significant differences in the OS and EFS were observed in the univariate analysis (HR = 13.349 and 7.112, p = 0.025 and 0.032, respectively); however, multivariate analysis did not identify EVI1high as an independent prognostic factor for the OS and EFS (HR = 13.056 and 10.091, p = 0.060 and 0.066, respectively; Table S2).